| Metformin as an adjuvant treatment for cancer: a systematic review and meta-analysis C Coyle, FH Cafferty, C Vale, RE Langley Annals of Oncology 27 (12), 2184-2195, 2016 | 424 | 2016 |
| Weekly dose-dense chemotherapy in first-line epithelial ovarian, fallopian tube, or primary peritoneal carcinoma treatment (ICON8): primary progression free survival analysis … AR Clamp, EC James, IA McNeish, A Dean, JW Kim, DM O'Donnell, ... The Lancet 394 (10214), 2084-2095, 2019 | 191 | 2019 |
| ADD-ASPIRIN: A phase III, double-blind, placebo controlled, randomised trial assessing the effects of aspirin on disease recurrence and survival after primary therapy in common … C Coyle, FH Cafferty, S Rowley, M MacKenzie, L Berkman, S Gupta, ... Contemporary clinical trials 51, 56-64, 2016 | 167* | 2016 |
| ADD-ASPIRIN: A phase III, double-blind, placebo controlled, randomised trial assessing the effects of aspirin on disease recurrence and survival after primary therapy in common … C Coyle, FH Cafferty, S Rowley, M MacKenzie, L Berkman, S Gupta, ... Contemporary clinical trials 51, 56-64, 2016 | 161 | 2016 |
| Prospective stage-stratified approach to AIDS-related Kaposi's sarcoma M Bower, A Dalla Pria, C Coyle, E Andrews, V Tittle, S Dhoot, M Nelson Journal of clinical oncology 32 (5), 409-414, 2014 | 133 | 2014 |
| ICON8: a GCIG phase III randomised trial evaluating weekly dose-dense chemotherapy integration in first-line epithelial ovarian/fallopian tube/primary peritoneal carcinoma (EOC … AR Clamp, I McNeish, A Dean, D Gallardo, J Weon-Kim, D O'Donnell, ... Annals of Oncology 28, v627, 2017 | 79 | 2017 |
| Aspirin and colorectal cancer prevention and treatment: is it for everyone? C Coyle, FH Cafferty, RE Langley Current colorectal cancer reports 12, 27-34, 2016 | 71 | 2016 |
| What is the optimal duration of human chorionic gonadotrophin surveillance following evacuation of a molar pregnancy? A retrospective analysis on over 20,000 consecutive patients C Coyle, D Short, L Jackson, NJ Sebire, B Kaur, R Harvey, PM Savage, ... Gynecologic oncology 148 (2), 254-257, 2018 | 56 | 2018 |
| Diagnostic criteria schemes for multicentric Castleman disease in 75 cases M Bower, A Dalla Pria, C Coyle, M Nelson, K Naresh JAIDS Journal of Acquired Immune Deficiency Syndromes 65 (2), e80-e82, 2014 | 30 | 2014 |
| Repurposing vitamin D as an anticancer drug DC Gilbert, C Vale, R Haire, C Coyle, RE Langley Clinical Oncology 28 (1), 36-41, 2016 | 17 | 2016 |
| Breast cancer in older patients: national cancer registry data R Sinha, C Coyle, A Ring International journal of clinical practice 67 (7), 698-700, 2013 | 17 | 2013 |
| Co-enrolment of participants into multiple cancer trials: benefits and challenges FH Cafferty, C Coyle, S Rowley, L Berkman, M MacKensie, RE Langley Clinical Oncology 29 (7), e126-e133, 2017 | 9 | 2017 |
| Emergency Etoposide-Cisplatin (Em-EP) for patients with germ cell tumours (GCT) and trophoblastic neoplasia (TN) C Chan Wah Hak, C Coyle, A Kocache, D Short, N Sarwar, MJ Seckl, ... BMC cancer 19, 1-9, 2019 | 8 | 2019 |
| 805O ICON8: Overall survival results in a GCIG phase III randomised controlled trial of weekly dose-dense chemotherapy in first line epithelial ovarian, fallopian tube or … AR Clamp, EC James, I McNeish, A Dean, JW Kim, DM O'Donnell, J Hook, ... Annals of Oncology 31, S610, 2020 | 7 | 2020 |
| Erythema nodosum as a result of estrogen patch therapy for prostate cancer: a case report C Coyle, S Mangar, P Abel, RE Langley Journal of Medical Case Reports 9, 1-3, 2015 | 5 | 2015 |
| Add-Aspirin trial: A phase III, double blind, placebo-controlled, randomized trial assessing the effects of aspirin on disease recurrence and survival after primary therapy in … RE Langley, RH Wilson, AE Ring, HG Kynaston, DA Cameron, C Coyle, ... Journal of Clinical Oncology 32 (15_suppl), TPS1617-TPS1617, 2014 | 5 | 2014 |
| Time to hCG normalisation in patients with hydatidiform molar pregnancy (HM) and risk of persistent gestational trophoblastic disease (PTD) C Coyle, D Short, L Dayal, L Horsley, N Sebire, B Kaur, R Harvey, ... Oral presentation at the ISSTD 2013 conference, 0 | 4 | |
| ICON8 stage 1A and 1B analysis: safety and feasibility of weekly carboplatin and paclitaxel regimens in first-line ovarian cancer EC James, J Hook, S Stenning, A Cook, C Coyle, J Petrie, R Kaplan, ... Annals of Oncology 27, vi297, 2016 | 3 | 2016 |
| AIDS-related malignancy M Bower, E Gervasi, A Dalla Pria Treatment of Cancer, 566-573, 2020 | 1 | 2020 |
| Repurposing medicines for the adjuvant treatment of cancer: An evaluation of aspirin and metformin C Coyle UCL (University College London), 2018 | 1 | 2018 |
